Evidence map›Paper›PMID 37520795›Full record

ReviewJournal of hazardous materials advances2022

A critical review on diverse technologies for advanced wastewater treatment during SARS-CoV-2 pandemic: What do we know?

Sasan Zahmatkesh, Kassian T T Amesho, Mika Sillanpää

Abstract readReview
In one paragraph

Review in Journal of hazardous materials advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Multifunctional MoSACS omega · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sasan ZahmatkeshDepartment of Chemical Engineering, University of Science and Technology of Mazandaran, P.O. Box 48518-78195, Behshahr, Iran.
Kassian T T AmeshoInstitute of Environmental Engineering, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Mika SillanpääFaculty of Science and Technology, School of Applied Physics, University Kebangsaan Malaysia, 43600, Bangi, Selangor, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced wastewater treatment technologies are effective methods and currently attract growing attention, especially in arid and semi-arid areas, for reusing water, reducing water pollution, and explicitly declining, inactivating, or removing SARS-CoV-2. Overall, removing organic matter and micropollutants prior to wastewater reuse is critical, considering that water reclamation can help provide a crop irrigation system and domestic purified water. Advanced wastewater treatment processes are highly recommended for contaminants such as monovalent ions from an abiotic source and SARS-CoV-2 from an abiotic source. This work introduces the fundamental knowledge of various methods in advanced water treatment, including membranes, filtration, Ultraviolet (UV) irradiation, ozonation, chlorination, advanced oxidation processes, activated carbon (AC), and algae. Following that, an analysis of each process for organic matter removal and mitigation or prevention of SARS-CoV-2 contamination is discussed. Next, a comprehensive overview of recent advances and breakthroughs is provided for each technology. Finally, the advantages and disadvantages of each method are discussed.

Indexed as

Activated carbonAdvanced oxidation processAlgaeAOP, advanced oxidation processBOD, biological oxygen demandChlorinationCOD, chemical oxygen demandDBP, disinfection by-productEPS, extracellular polymeric substancesGAC, granular activated carbonMembraneMicropollutantsOzonationPAC, powdered activated carbonSARS-CoV-2TOC, total organic carbonTSS, total suspended solidsUV irradiationUV, ultravioletWastewaterWWTPs, wastewater treatment plants

Identifiers

PMID37520795
PMCPMC9250822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.